Limitations, agreements, and source contact

Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma · Source last updated 2019-09-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

SAEs not recorded for participants off study, though they were followed for survival.

point Of Contact

email

melissa.alsina@moffitt.org

organization

H. Lee Moffitt Cancer Center and Research Institute

phone

813-745-7202

title

Dr. Melissa Alsina

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice